Science & Enterprise subscription

Follow us on Twitter

  • A smartphone app is collecting individual reports about Covid-19 symptoms and other health conditions to provide ea… https://t.co/gxdMGhThvO
    about 14 hours ago
  • New post on Science and Enterprise: Phone App Tracking Covid-19 Symptom Reports https://t.co/67W6hKYsQe #Science #Business
    about 14 hours ago
  • A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license… https://t.co/R1SLXtUQXg
    about 20 hours ago
  • New post on Science and Enterprise: Start-Up Licenses Immunotherapies in $880M Deal https://t.co/udtVXhqw7K #Science #Business
    about 20 hours ago
  • CRISPR pioneer Doudna opens lab to run Covid-19 tests ... Also Broad Inst. ... https://t.co/7QGSFzgJfP via @statnews
    about 23 hours ago

Please share Science & Enterprise

Sanofi, Biotech Partner on RNA Covid-19 Vaccine

SARS-Cov-2 virus

Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine

Engineered Blood Cells Created for Cancer Therapies

Macrophage

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies

Engineered Probiotic Maker Gains $2.3M Seed Funding

Zack Abbott and John Oliver

A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line. . . . → Read More: Engineered Probiotic Maker Gains $2.3M Seed Funding

Business-Foundation Alliance Funds Covid-19 Treatments

Coronavirus graphic

Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic. . . . → Read More: Business-Foundation Alliance Funds Covid-19 Treatments

Venom-Aided Immunotherapy Designed for Brain Tumors

Death stalker scorpion

Cancer researchers developed engineered immune-system cells, helped by peptides from scorpion venom, that in lab mice bind more reliably to brain tumor cells. . . . → Read More: Venom-Aided Immunotherapy Designed for Brain Tumors

Foundation Supports ALS Inflammation Treatments

Brain activity graphic

A foundation is funding a biotechnology company’s research on therapies to block proteins encouraging neuron inflammation in people with amyotrophic lateral sclerosis, or ALS. . . . → Read More: Foundation Supports ALS Inflammation Treatments

Wireless Smart Bandage Designed for Chronic Wounds

Hand bandage

A university lab developed a wirelessly-controlled programmable bandage that in tests with lab mice results in more diabetic wound closure than topical medicines. . . . → Read More: Wireless Smart Bandage Designed for Chronic Wounds

Engineered Bacteria Deliver Cancer Immunotherapy

E. coli

Escherichia coli, or E. coli, bacteria (National Institute of Allergy and Infectious Diseases)

13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of . . . → Read More: Engineered Bacteria Deliver Cancer Immunotherapy

Synthetic Cell Matrix Devised for Cancer Drug Testing

Honeycomb scaffold

A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs. . . . → Read More: Synthetic Cell Matrix Devised for Cancer Drug Testing

Nasal Spray Reduces Migraine-Related Stress, Peptides

Richard Kraig

A hormone resembling insulin given as a nasal spray is shown in lab rats to reduce stress on nerve cells and peptides associated with migraine pain. . . . → Read More: Nasal Spray Reduces Migraine-Related Stress, Peptides